Foscavir receives new indication.
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy; D000998:Antiviral Agents / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D017245:Foscarnet / Q000627:therapeutic use*; D015774:Ganciclovir / Q000627:therapeutic use; D006561:Herpes Simplex / Q000188:drug therapy; D006801:Humans; D014481:United States; D014486:United States Food and Drug Administration
D000998:Antiviral Agents; D017245:Foscarnet; D015774:Ganciclovir